Mattias N D Svensson
Overview
Explore the profile of Mattias N D Svensson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu Z, Deshmukh M, Jarneborn A, Bollmann M, Corciulo C, Kopparapu P, et al.
JCI Insight
. 2025 Mar;
10(6).
PMID: 40067374
Septic arthritis, the most severe joint disease, is frequently caused by Staphylococcus aureus (S. aureus). A substantial proportion of patients with septic arthritis experience poor joint outcomes, often necessitating joint...
2.
Bergstrom B, Sellden T, Bollmann M, Svensson M, Hultgard Ekwall A
Arthritis Res Ther
. 2024 Oct;
26(1):178.
PMID: 39394168
Background: Activated fibroblast-like synoviocytes (FLS) are drivers of synovitis and structural joint damage in rheumatoid arthritis (RA). Despite the use of disease-modifying drugs, only about 50% of RA patients reach...
3.
Johnson W, McBride D, Kerr M, Nguyen A, Zoccheddu M, Bollmann M, et al.
ACS Nano
. 2023 Nov;
18(3):1892-1906.
PMID: 38016062
Disease-modifying drugs have improved the treatment for autoimmune joint disorders, such as rheumatoid arthritis, but inflammatory flares are a common experience. This work reports the development and application of flare-modulating...
4.
McBride D, Kerr M, Johnson W, Nguyen A, Zoccheddu M, Yao M, et al.
Adv Sci (Weinh)
. 2023 Mar;
10(11):e2202720.
PMID: 36890657
Disease modifying antirheumatic drugs (DMARDs) have improved the prognosis of autoimmune inflammatory arthritides but a large fraction of patients display partial or nonresponsiveness to front-line DMARDs. Here, an immunoregulatory approach...
5.
Ainsworth R, Hammaker D, Nygaard G, Ansalone C, Machado C, Zhang K, et al.
Nat Commun
. 2022 Oct;
13(1):6221.
PMID: 36266270
Rheumatoid arthritis (RA) is an immune-mediated disease affecting diarthrodial joints that remains an unmet medical need despite improved therapy. This limitation likely reflects the diversity of pathogenic pathways in RA,...
6.
Stockfelt M, Larsson G, Engstrom H, Puttonen H, Zetterberg H, Blennow K, et al.
Lupus Sci Med
. 2021 Mar;
8(1).
PMID: 33685997
Objective: Women with SLE face an increased risk of adverse pregnancy outcomes compared with healthy women, but the underlying immunological mechanisms are unknown. Given the recognised association of neutrophil activation...
7.
Svensson M, Zoccheddu M, Yang S, Nygaard G, Secchi C, Doody K, et al.
Sci Adv
. 2020 Jul;
6(26):eaba4353.
PMID: 32637608
Fibroblast-like synoviocytes (FLS) are joint-lining cells that promote rheumatoid arthritis (RA) pathology. Current disease-modifying antirheumatic agents (DMARDs) operate through systemic immunosuppression. FLS-targeted approaches could potentially be combined with DMARDs to...
8.
Yang S, Svensson M, Harder N, Hsieh W, Santelli E, Kiosses W, et al.
Sci Signal
. 2020 Mar;
13(623).
PMID: 32184287
The hematopoietic-specific protein tyrosine phosphatase nonreceptor type 22 (PTPN22) is encoded by a major autoimmunity risk gene. PTPN22 inhibits T cell activation by dephosphorylating substrates involved in proximal T cell...
9.
Wen Y, Yang S, Wakabayashi K, Svensson M, Stanford S, Santelli E, et al.
J Biol Chem
. 2020 Mar;
295(15):4923-4936.
PMID: 32139509
Receptor-type protein tyrosine phosphatase α (RPTPα) is an important positive regulator of SRC kinase activation and a known promoter of cancer growth, fibrosis, and arthritis. The domain structure of RPTPs...
10.
Zhao M, Svensson M, Venken K, Chawla A, Liang S, Engel I, et al.
Nat Commun
. 2018 Jul;
9(1):2627.
PMID: 29980684
Various subsets of invariant natural killer T (iNKT) cells with different cytokine productions develop in the mouse thymus, but the factors driving their differentiation remain unclear. Here we show that...